Solventum (SOLV) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual meeting scheduled for May 15, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 14, 2026, or May 12, 2026, for plan shares.
Voting matters and shareholder proposals
Election of four directors: Carlos Albán, Susan D. DeVore, Shirley Edwards, and Dr. Bernard A. Harris Jr., all recommended for approval.
Advisory vote on executive compensation (say-on-pay) recommended for approval.
Ratification of PwC as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended for approval.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Latest events from Solventum
- Annual meeting to vote on directors, pay, and auditor, with strong results and governance focus.SOLV
Proxy filing27 Mar 2026 - Transformation on track, with strong growth, margin expansion, and innovation driving outlook.SOLV
2026 KeyBanc Capital Markets Healthcare Forum18 Mar 2026 - Organic sales up 3.3% in FY25; 2026 guidance targets growth, margin gains, and higher EPS.SOLV
Q4 202527 Feb 2026 - Strong growth, innovation, and portfolio moves set the stage for accelerated expansion by 2026.SOLV
Stifel 2025 Healthcare Conference3 Feb 2026 - Q2 organic sales rose 1.3% to $2.081B; 2024 guidance and adjusted EPS were raised.SOLV
Q2 20242 Feb 2026 - Transformation plan ahead of schedule, with raised guidance and operational improvements underway.SOLV
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Transformation focuses on growth, IP leverage, and operational efficiency across core segments.SOLV
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 sales rose 0.4% and guidance was raised, but margins fell on spin-off and transition costs.SOLV
Q3 202415 Jan 2026 - Transformation underway with focus on growth markets, operational streamlining, and portfolio optimization.SOLV
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026